News from viking therapeutics, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 16, 2022, 16:05 ET Viking Therapeutics to Present at H.C. Wainwright Global Investment Conference

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Apr 27, 2022, 16:08 ET Viking Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Apr 20, 2022, 16:05 ET Viking Therapeutics to Report Financial Results for First Quarter 2022 on April 27, 2022

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Apr 06, 2022, 16:05 ET Viking Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Mar 08, 2022, 16:05 ET Viking Therapeutics to Present at Upcoming Investor Conferences

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Feb 09, 2022, 16:05 ET Viking Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Feb 07, 2022, 16:05 ET Viking Therapeutics to Present at SVB Leerink 11th Annual Global Healthcare Conference

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Feb 02, 2022, 16:05 ET Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2021 on February 9, 2022

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jan 24, 2022, 07:02 ET Viking Therapeutics Announces Clinical Hold on Phase 1b Trial of VK0214 in Patients with X-ALD

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jan 10, 2022, 07:02 ET Viking Therapeutics Announces Initiation of Phase 1 Clinical Trial of VK2735, Company's Lead Dual GLP-1/GIP Receptor Agonist

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jan 03, 2022, 07:30 ET Viking Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Nov 09, 2021, 16:05 ET Viking Therapeutics to Present at Stifel 2021 Virtual Healthcare Conference

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Nov 03, 2021, 16:05 ET Viking Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Nov 01, 2021, 07:03 ET Viking Therapeutics Presents Preclinical Data on Novel Dual GLP-1/GIP Agonists at ObesityWeek® 2021

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Oct 27, 2021, 16:05 ET Viking Therapeutics to Report Financial Results for Third Quarter 2021 on November 3, 2021

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Oct 25, 2021, 07:05 ET Viking Therapeutics to Present Preclinical Data on Novel Dual GLP-1/GIP Agonists at ObesityWeek 2021

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Oct 05, 2021, 16:05 ET Viking Therapeutics to Present at H.C. Wainwright's 5th Annual NASH Investor Conference

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Sep 02, 2021, 16:05 ET Viking Therapeutics to Participate in Upcoming Investor Conferences

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jul 28, 2021, 16:05 ET Viking Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jul 21, 2021, 16:05 ET Viking Therapeutics to Report Financial Results for Second Quarter 2021 on July 28, 2021

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jun 24, 2021, 07:05 ET Viking Therapeutics Announces Initiation of Phase 1b Clinical Trial of VK0214 in Patients with X-ALD

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jun 17, 2021, 07:05 ET Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Novel Oral Thyroid Receptor Beta Agonist VK0214

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Jun 10, 2021, 16:05 ET Viking Therapeutics to Participate in Upcoming Investor Conferences

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Apr 28, 2021, 16:05 ET Viking Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Apr 21, 2021, 16:05 ET Viking Therapeutics to Report Financial Results for First Quarter 2021 on April 28, 2021

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...